Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Global Bio-chem Technology Group Co. Ltd. ( (HK:0809) ) has shared an update.
Global Bio-chem Technology Group plans a 10-for-1 consolidation of its existing shares and convertible preference shares, raising the par value of each from HK$0.10 to HK$1.00 while keeping the authorised share capital unchanged. The move will sharply reduce the number of shares in issue, with the change subject to shareholder approval at the forthcoming annual general meeting.
Conditional on the consolidation taking effect, the company will also increase the trading board lot size on the Hong Kong Stock Exchange from 2,000 existing shares to 10,000 consolidated shares, a step that typically targets higher per-lot valuations and improved trading efficiency. The proposals may or may not proceed depending on fulfilment of conditions, and investors are urged to exercise caution as these capital structure changes could affect liquidity and market perception of the stock.
The most recent analyst rating on (HK:0809) stock is a Sell with a HK$0.06 price target. To see the full list of analyst forecasts on Global Bio-chem Technology Group Co. Ltd. stock, see the HK:0809 Stock Forecast page.
More about Global Bio-chem Technology Group Co. Ltd.
Global Bio-chem Technology Group Company Limited is a Cayman Islands-incorporated company listed in Hong Kong, operating in the biotechnology and chemicals sector. The group focuses on corn-based biochemical products and related technologies, serving industrial and consumer markets that rely on bio-chemical inputs and materials.
Average Trading Volume: 4,945,762
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.01B
Learn more about 0809 stock on TipRanks’ Stock Analysis page.